Attached files
| file | filename |
|---|---|
| EX-12.1 - EXHIBIT 12.1 - DOW CHEMICAL CO /DE/ | dow-q1x3312016ex121.htm |
| EX-31.A - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - DOW CHEMICAL CO /DE/ | dow-q1x3312016ex31a.htm |
| EX-31.B - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - DOW CHEMICAL CO /DE/ | dow-q1x3312016ex31b.htm |
| EX-32.B - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - DOW CHEMICAL CO /DE/ | dow-q1x3312016ex32b.htm |
| 10-Q - 10-Q - DOW CHEMICAL CO /DE/ | dow-q1x3312016.htm |
| EX-32.A - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - DOW CHEMICAL CO /DE/ | dow-q1x3312016ex32a.htm |
Ankura Consulting Group, LLC's Consent | EXHIBIT 23 | |
The Dow Chemical Company:
Ankura Consulting Group, LLC (“Ankura”) hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Quarterly Report on Form 10-Q of The Dow Chemical Company for the period ended March 31, 2016, and the incorporation by reference thereof in the following Registration Statements of The Dow Chemical Company and Subsidiaries:
Form S-4: | |
No. | 333-88443 |
333-209869 | |
Form S-8: | |
Nos. | 33-21748 |
33-52841 | |
33-61795 | |
333-27381 | |
333-40271 | |
333-43730 | |
333-67414 | |
333-91027 | |
333-103518 | |
333-103519 | |
333-105080 | |
333-122932 | |
333-145015 | |
333-162910 | |
333-181356 | |
333-199664 | |
333-207634 | |
333-209581 | |
333-209582 | |
/s/ B. THOMAS FLORENCE |
B. Thomas Florence |
Senior Managing Director |
Ankura Consulting Group, LLC |
April 22, 2016 |
58